Competing interests
M.M. holds equity in MapLight Therapeutics. M.M. reports the patent (US Patent 10,377,818) ‘Method for treating glioma’. F.W. reports the patent (WO2017020982A1) ‘Agents for use in the treatment of glioma’. F.W. is a co-founder of DC Europa Ltd (a company trading under the name Divide & Conquer) that is developing new medicines for the treatment of glioma. Divide & Conquer also provides research funding to F.W.’s lab under a research collaboration agreement.
